Current advances and challenges in HIV-1 vaccines

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Significant scientific progress has been made in understanding the Human Immunodeficiency Virus type 1 (HIV-1) envelope structure and function.
• The pipeline for HIV-1 vaccine development has expanded with novel strategies and promising multi-gene, multi-clade vaccines designed to induce cellular immunity.

Purpose of the Study:

• To summarize recent advances in HIV-1 vaccine development.
• To highlight innovative vaccine strategies currently in clinical trials.
• To discuss the development of techniques for measuring immune responses to vaccines.

Main Methods:

• Improved understanding of HIV-1 envelope structure and function.
• Development and implementation of innovative vaccine strategies.
• Conduct of clinical trials in a global network.
• Development of validated techniques for simultaneous measurement of multiple T cell vaccine-induced immune responses.

Main Results:

• Several preventive vaccine strategies in early clinical trials show potential to attenuate clinical disease in nonhuman primates, rather than completely prevent infection.
• One vaccine concept has undergone large-scale clinical trials, two are in efficacy trials, and another is expected to enter efficacy trials soon.
• Ongoing efforts focus on developing vaccine designs that induce mucosal immunity and broadly neutralizing antibodies.

Conclusions:

• Recent scientific advancements are accelerating HIV-1 vaccine development, with a focus on disease attenuation and eliciting robust immune responses.
• Multiple vaccine candidates are progressing through clinical trials, indicating a dynamic and evolving field.
• Future research aims to induce mucosal immunity and broadly neutralizing antibodies for comprehensive protection against HIV-1.